Skip to main navigation

Main navigation

  • about
  • our approach
  • our pipeline
  • investors & media
  • join #onejounce
  • contact us

Main navigation

  • about
  • our approach
  • our pipeline
  • investors & media
  • join #onejounce
  • contact us
follow
contact
our media

Investors & Media

SEC Filing Details

Document Details

Form
10-Q
Filing Date
Nov 13, 2018
Document Date
Sep 30, 2018
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Jounce Therapeutics, Inc.
Issuer
Jounce Therapeutics, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.INS - XBRL INSTANCE DOCUMENT
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT

IR menu

  • Investor Overview
  • Press Releases
  • Events & Presentations
  • Stock Information
  • Analyst Coverage
  • Publications
  • Financial Information
  • Annual Meeting
  • Corporate Governance
  • Email Alerts
  • Investor FAQs

Shareholder Tools

  • Print Page
  • RSS Feeds
  • Contact IR

Pages

  • Home
  • About
  • Our Approach
  • Our Pipeline
  • Investors and Media
  • Join #OneJounce
  • Career Opportunities

Resources

  • Press Releases
  • ContactContact

Leadership

  • Management Team
  • Board of Directors
  • Company Founders

Focus

  • Pipeline Overview
  • T Cell Approach
  • Beyond T Cell

© Jounce Therapeutics, Inc. All rights reserved. | Privacy Policy | Terms of Use

Contact Us

Jounce Therapeutics, Inc.
780 Memorial Drive
Cambridge, MA 02139
Phone: (857) 259-3840
Fax: (888) 459-2940
For media inquiries, please contact:
Malin Deon
(857) 259-3843 or
mdeon@jouncetx.com

Mark Yore
(857) 200-1255 or
myore@jouncetx.com